reference/11284812

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11284812

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	415
issn	0742-3071 1464-5491
issueIdentifier	4
pageRange	409-415
publicationName	Diabetic medicine : a journal of the British Diabetic Association
startingPage	409
bibliographicCitation	Juurinen L, Tiikkainen M, Saltevo J, Nikkilä K, Lanki H, Leppävuori E, Kock T, Teikari-Myyrä T, Kauppinen-Mäkelin R, Kotronen A, Yki-Järvinen H. Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes. Diabet Med. 2009 Apr;26(4):409–15. doi: 10.1111/j.1464-5491.2009.02691.x. PMID: 19388972.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be0659e5c59a4a4762cce01f483b252f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a2a31df4584fb5c434d022a5237410f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2de7b59b1de9684688dab266b9c9a644 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be0a8810e18908a358ed69abf0675d1c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ddb6f72ea4d6f7e6713393073e1689a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a2887f23099abe10bf6bc65773a3f9a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de76758182b1312d7dca1bc641c54da1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a9289cb86da67139b081460c46e4a5f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5cc5aafb076dd5acb39259f463ad036 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_975c5d0b47799e7f0296a8eca37175e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b890f7960f264efc689ae22868409b82
date	200904
identifier	https://doi.org/10.1111/j.1464-5491.2009.02691.x https://pubmed.ncbi.nlm.nih.gov/19388972
isPartOf	https://portal.issn.org/resource/ISSN/1464-5491 https://portal.issn.org/resource/ISSN/0742-3071 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3095
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes
discusses	http://id.nlm.nih.gov/mesh/M0353981 http://id.nlm.nih.gov/mesh/M0013535 http://id.nlm.nih.gov/mesh/M0016544 http://id.nlm.nih.gov/mesh/M0010114 http://id.nlm.nih.gov/mesh/M0010903 http://id.nlm.nih.gov/mesh/M0005469 http://id.nlm.nih.gov/mesh/M0011417
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D010649Q000031 http://id.nlm.nih.gov/mesh/D008687Q000008 http://id.nlm.nih.gov/mesh/D007004Q000008 http://id.nlm.nih.gov/mesh/D003510Q000008 http://id.nlm.nih.gov/mesh/D007328Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D006442Q000187 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D010649Q000008 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D007003Q000188 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D019518 http://id.nlm.nih.gov/mesh/D000077715
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311309 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8072 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_55029e08d2afcf59a719caf55a149021 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8121 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fa5fc799a3f3c6277beeb3473c262800 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129765044 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128797137

Total number of triples: 71.